Table 3.
Self-Care Symptom Management Strategy by Self-Efficacy
| Bivariate analyses–self care symptom management strategy type used | ||||
|---|---|---|---|---|
| Self care symptom management category n=569 | High self efficacy group (HSE) | Low self efficacy group (LSE) | Value | p |
| Thoughts and activities frequency – (mean rank) | 272.86 | 299.37 | ZU=1.91 | p=0.056 (CI=0.050–0.062) |
| Taking prescribed and OTC medications therapies frequency – (mean rank) | 271.92 | 300.13 | ZU=2.17 | p=0.030 |
| Exercise frequency – (mean rank) | 281.10 | 292.69 | ZU=0.870 | p=0.38 |
| Complementary therapies frequency – (mean rank) | 282.46 | 291.59 | ZU=0.687 | p=0.49 |
| Substance use frequency–(mean rank) | 271.78 | 300.25 | ZU=0.025 | p=0.025 |
| Thoughts and activities effectiveness – (mean rank) | 276.01 | 296.82 | ZU=1.51 | p=0.13 |
| Taking prescribed and OTC medications therapies effectiveness – (mean rank) | 278.37 | 294.91 | ZU=1.25 | p=0.21 |
| Exercise effectiveness–(mean rank) | 285.92 | 288.78 | ZU=0.22 | p=0.83 |
| Complementary therapies effectiveness–(mean rank) | 286.66 | 288.06 | ZU=0.20 | p=0.82 |
| Substance use effectiveness-(mean rank) | 273.67 | 298.71 | ZU=1.98 | p=0.04 |
| HIV assessment tool (HAT) | ||||
| HIV control over illness (taking/not taking ART) | 75.34 (SD=26.0) | 56.70 (SD=29.9) | t=4.20 | p≤0.001 |
| Engagement with health care provider (HCP) | ||||
| HCP total score (lower score=improved engagement) | 14 | 17 | t= | p≤0.001 |
| Symptom frequency (SSC-HIV rev) total score (range 0–64) | ||||
| Baseline | 19.40 (SD=17.9) | 23.0 (SD=19.5) | F=5.90 | p=0.015 |
| Assessment 1 | 17.37 (SD=15.8) | 20.62 (SD=19.8) | ||
| Assessment 2 | 14.02 (SD=13.9) | 17.97 (SD=18.5) | ||
ZU, Mann–Whitney nonparametric statistical test; ART, antiretroviral therapy.